 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jun 16, 2024 |
| Title |
A Mouse Model for Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatocellular Carcinoma |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Contributor(s) |
Jeong B, Choi W, Choi W, Lee W, Park J, Kim H |
| Citation(s) |
39090079 |
| |
| Submission date |
Oct 25, 2023 |
| Last update date |
Aug 21, 2024 |
| Contact name |
Byung-Kwan Jeong |
| E-mail(s) |
goodididid@gmail.com
|
| Organization name |
Asan Medical Center
|
| Department |
Pathology
|
| Street address |
88, Olympic-ro 43-gil
|
| City |
Songpa-Gu |
| State/province |
Seoul |
| ZIP/Postal code |
05505 |
| Country |
South Korea |
| |
|
| Platforms (3) |
| GPL21273 |
HiSeq X Ten (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (160)
|
| GSM7864924 |
ATAC-seq of control SCD fed mice without STZ treatment, 20w, biological replication 1 |
| GSM7864925 |
ATAC-seq of control SCD fed mice without STZ treatment, 20w, biological replication 2 |
| GSM7864926 |
ATAC-seq of control SCD fed mice without STZ treatment, 20w, biological replication 3 |
| GSM7864927 |
ATAC-seq of STZ+ SCD mice, 20w, biological replication 1 |
| GSM7864928 |
ATAC-seq of STZ+ SCD mice, 20w, biological replication 2 |
| GSM7864929 |
ATAC-seq of STZ+ SCD mice, 20w, biological replication 3 |
| GSM7864930 |
ATAC-seq of HFD fed mice without STZ treatment, 20w, biological replication 1 |
| GSM7864931 |
ATAC-seq of HFD fed mice without STZ treatment, 20w, biological replication 2 |
| GSM7864932 |
ATAC-seq of HFD fed mice without STZ treatment, 20w, biological replication 3 |
| GSM7864933 |
ATAC-seq of STZ+HFD model, 20w, biological replication 1 |
| GSM7864934 |
ATAC-seq of STZ+HFD model, 20w, biological replication 2 |
| GSM7864935 |
ATAC-seq of STZ+HFD model, 20w, biological replication 3 |
| GSM7865084 |
Healthy control,7w, biological replication 1 |
| GSM7865085 |
Healthy control,7w, biological replication 2 |
| GSM7865086 |
Healthy control,7w, biological replication 3 |
| GSM7865087 |
Healthy control,7w, biological replication 4 |
| GSM7865088 |
Healthy control,7w, biological replication 5 |
| GSM7865089 |
Acutre streptozotocin-treated state,8w, biological replication 1 |
| GSM7865090 |
Acutre streptozotocin-treated state,8w, biological replication 2 |
| GSM7865091 |
Acutre streptozotocin-treated state,8w, biological replication 3 |
| GSM7865092 |
STZ+HFD model, 14w, biological replication 1 |
| GSM7865093 |
STZ+HFD model, 14w, biological replication 2 |
| GSM7865094 |
STZ+HFD model, 14w, biological replication 3 |
| GSM7865095 |
STZ+HFD model, 14w, biological replication 4 |
| GSM7865096 |
STZ+HFD model, 14w, biological replication 5 |
| GSM7865097 |
STZ+HFD model, 20w, biological replication 1 |
| GSM7865098 |
STZ+HFD model, 20w, biological replication 2 |
| GSM7865099 |
STZ+HFD model, 20w, biological replication 3 |
| GSM7865100 |
STZ+HFD model, 20w, biological replication 4 |
| GSM7865101 |
STZ+HFD model, 20w, biological replication 5 |
| GSM7865102 |
STZ+HFD model, 32w, biological replication 1 |
| GSM7865103 |
STZ+HFD model, 32w, biological replication 2 |
| GSM7865104 |
STZ+HFD model, 32w, biological replication 3 |
| GSM7865105 |
STZ+HFD model, 32w, biological replication 4 |
| GSM7865106 |
STZ+HFD model, 32w, biological replication 5 |
| GSM7865107 |
STZ+HFD model, 44w, biological replication 1 |
| GSM7865108 |
STZ+HFD model, 44w, biological replication 2 |
| GSM7865109 |
STZ+HFD model, 44w, biological replication 3 |
| GSM7865110 |
STZ+HFD model, 44w, biological replication 4 |
| GSM7865111 |
STZ+HFD model, 44w, biological replication 5 |
| GSM7865112 |
STZ+HFD model, 50w, biological replication 1 |
| GSM7865113 |
STZ+HFD model, 50w, biological replication 2 |
| GSM7865114 |
STZ+HFD model, 50w, biological replication 3 |
| GSM7865115 |
STZ+HFD model, 50w, biological replication 4 |
| GSM7865116 |
STZ+HFD model, 56w, biological replication 1 |
| GSM7865117 |
STZ+HFD model, 56w, biological replication 2 |
| GSM7865118 |
STZ+HFD model, 56w, biological replication 3 |
| GSM7865119 |
STZ+HFD model, 56w, biological replication 4 |
| GSM7865120 |
STZ+HFD model, 56w, biological replication 5 |
| GSM7865121 |
STZ+HFD model, 56w, biological replication 6 |
| GSM7865122 |
STZ+HFD model, 44w, hepatic tumor ID 03 |
| GSM7865123 |
STZ+HFD model, 44w, hepatic tumor ID 04 |
| GSM7865124 |
STZ+HFD model, 44w, hepatic tumor ID 05 |
| GSM7865125 |
STZ+HFD model, 44w, hepatic tumor ID 06 |
| GSM7865126 |
STZ+HFD model, 50w, hepatic tumor ID 07 |
| GSM7865127 |
STZ+HFD model, 50w, hepatic tumor ID 09 |
| GSM7865128 |
STZ+HFD model, 50w, hepatic tumor ID 10 |
| GSM7865129 |
STZ+HFD model, 50w, hepatic tumor ID 11 |
| GSM7865130 |
STZ+HFD model, 56w, hepatic tumor ID 13 |
| GSM7865131 |
STZ+HFD model, 56w, hepatic tumor ID 14 |
| GSM7865132 |
STZ+HFD model, 56w, hepatic tumor ID 18 |
| GSM7865133 |
STZ+HFD model, 56w, hepatic tumor ID 22 |
| GSM7865134 |
STZ+HFD model, 56w, hepatic tumor ID 24 |
| GSM7865135 |
STZ+HFD model, 56w, hepatic tumor ID 25 |
| GSM7865136 |
Control SCD fed mice without STZ treatment, 20w, biological replication 1 |
| GSM7865137 |
Control SCD fed mice without STZ treatment, 20w, biological replication 2 |
| GSM7865138 |
Control SCD fed mice without STZ treatment, 20w, biological replication 3 |
| GSM7865139 |
Control SCD fed mice without STZ treatment, 20w, biological replication 4 |
| GSM7865140 |
STZ+ SCD mice, 20w, biological replication 1 |
| GSM7865141 |
STZ+ SCD mice, 20w, biological replication 2 |
| GSM7865142 |
STZ+ SCD mice, 20w, biological replication 3 |
| GSM7865143 |
HFD fed mice without STZ treatment, 20w, biological replication 1 |
| GSM7865144 |
HFD fed mice without STZ treatment, 20w, biological replication 2 |
| GSM7865145 |
HFD fed mice without STZ treatment, 20w, biological replication 3 |
| GSM7865146 |
HFD fed mice without STZ treatment, 20w, biological replication 4 |
| GSM7865147 |
HFD fed mice without STZ treatment, 20w, biological replication 5 |
| GSM7865148 |
STZ+HFD model, 26w, without dietary intervention, biological replication 1 |
| GSM7865149 |
STZ+HFD model, 26w, without dietary intervention, biological replication 2 |
| GSM7865150 |
STZ+HFD model, 26w, without dietary intervention, biological replication 3 |
| GSM7865151 |
STZ+HFD model, 26w, without dietary intervention, biological replication 4 |
| GSM7865152 |
STZ+HFD model, 26w, dietary change to SCD for 6 weeks, biological replication 1 |
| GSM7865153 |
STZ+HFD model, 26w, dietary change to SCD for 6 weeks, biological replication 2 |
| GSM7865154 |
STZ+HFD model, 26w, dietary change to SCD for 6 weeks, biological replication 3 |
| GSM7865155 |
STZ+HFD model, 26w, dietary change to SCD for 6 weeks, biological replication 4 |
| GSM7865156 |
STZ+HFD model, 50w, without dietary intervention, biological replication 1 |
| GSM7865157 |
STZ+HFD model, 50w, without dietary intervention, biological replication 2 |
| GSM7865158 |
STZ+HFD model, 50w, without dietary intervention, biological replication 3 |
| GSM7865159 |
STZ+HFD model, 50w, without dietary intervention, biological replication 4 |
| GSM7865160 |
STZ+HFD model, 50w, dietary change to SCD for 18 weeks, biological replication 1 |
| GSM7865161 |
STZ+HFD model, 50w, dietary change to SCD for 18 weeks, biological replication 2 |
| GSM7865162 |
STZ+HFD model, 50w, dietary change to SCD for 18 weeks, biological replication 3 |
| GSM7865163 |
STZ+HFD model, 50w, dietary change to SCD for 18 weeks, biological replication 4 |
| GSM7865164 |
STZ+HFD model, 32w, treated with control vehicle for 11 weeks, biological replication 1 |
| GSM7865165 |
STZ+HFD model, 32w, treated with control vehicle for 11 weeks, biological replication 2 |
| GSM7865166 |
STZ+HFD model, 32w, treated with control vehicle for 11 weeks, biological replication 3 |
| GSM7865167 |
STZ+HFD model, 32w, treated with control vehicle for 11 weeks, biological replication 4 |
| GSM7865168 |
STZ+HFD model, 32w, treated with control vehicle for 11 weeks, biological replication 5 |
| GSM7865169 |
STZ+HFD model, 32w, treated with tirzepatide (109.5 nmol/kg) for 11 weeks, biological replication 1 |
| GSM7865170 |
STZ+HFD model, 32w, treated with tirzepatide (109.5 nmol/kg) for 11 weeks, biological replication 2 |
| GSM7865171 |
STZ+HFD model, 32w, treated with tirzepatide (109.5 nmol/kg) for 11 weeks, biological replication 3 |
| GSM7865172 |
STZ+HFD model, 32w, treated with tirzepatide (109.5 nmol/kg) for 11 weeks, biological replication 4 |
| GSM7865173 |
STZ+HFD model, 32w, treated with tirzepatide (109.5 nmol/kg) for 11 weeks, biological replication 5 |
| GSM7865174 |
STZ+HFD model, 38w, treated with control vehicle for 10 weeks, biological replication 1 |
| GSM7865175 |
STZ+HFD model, 38w, treated with control vehicle for 10 weeks, biological replication 2 |
| GSM7865176 |
STZ+HFD model, 38w, treated with control vehicle for 10 weeks, biological replication 3 |
| GSM7865177 |
STZ+HFD model, 38w, treated with control vehicle for 10 weeks, biological replication 4 |
| GSM7865178 |
STZ+HFD model, 38w, treated with tirzepatide (109.5 nmol/kg) for 10 weeks, biological replication 1 |
| GSM7865179 |
STZ+HFD model, 38w, treated with tirzepatide (109.5 nmol/kg) for 10 weeks, biological replication 2 |
| GSM7865180 |
STZ+HFD model, 38w, treated with tirzepatide (109.5 nmol/kg) for 10 weeks, biological replication 3 |
| GSM7865181 |
STZ+HFD model, 38w, treated with tirzepatide (109.5 nmol/kg) for 10 weeks, biological replication 4 |
| GSM7865182 |
STZ+HFD model, 52w, treated with control vehicle for 11 weeks, biological replication 1 |
| GSM7865183 |
STZ+HFD model, 52w, treated with control vehicle for 11 weeks, biological replication 2 |
| GSM7865184 |
STZ+HFD model, 52w, treated with control vehicle for 11 weeks, biological replication 3 |
| GSM7865185 |
STZ+HFD model, 52w, treated with control vehicle for 11 weeks, biological replication 4 |
| GSM7865186 |
STZ+HFD model, 52w, treated with tirzepatide (109.5 nmol/kg) for 11 weeks, biological replication 1 |
| GSM7865187 |
STZ+HFD model, 52w, treated with tirzepatide (109.5 nmol/kg) for 11 weeks, biological replication 2 |
| GSM7865188 |
STZ+HFD model, 52w, treated with tirzepatide (109.5 nmol/kg) for 11 weeks, biological replication 3 |
| GSM7865189 |
STZ+HFD model, 52w, treated with tirzepatide (109.5 nmol/kg) for 11 weeks, biological replication 4 |
| GSM7865190 |
Healthy liver donor, biological replication 1 |
| GSM7865191 |
Healthy liver donor, biological replication 2 |
| GSM7865192 |
Healthy liver donor, biological replication 3 |
| GSM7865193 |
Healthy liver donor, biological replication 4 |
| GSM7865194 |
NAFLD patient, NAFLD activity score 2-3, fibrosis stage 1, biological replication 1 |
| GSM7865195 |
NAFLD patient, NAFLD activity score 2-3, fibrosis stage 1, biological replication 2 |
| GSM7865196 |
NAFLD patient, NAFLD activity score 2-3, fibrosis stage 1, biological replication 3 |
| GSM7865197 |
NAFLD patient, NAFLD activity score 2-3, fibrosis stage 1, biological replication 4 |
| GSM7865198 |
NAFLD patient, NAFLD activity score 2-3, fibrosis stage 1, biological replication 5 |
| GSM7865199 |
NAFLD patient, NAFLD activity score 2-3, fibrosis stage 1, biological replication 6 |
| GSM7865200 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 1, biological replication 1 |
| GSM7865201 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 1, biological replication 2 |
| GSM7865202 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 1, biological replication 3 |
| GSM7865203 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 1, biological replication 4 |
| GSM7865204 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 1, biological replication 5 |
| GSM7865205 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 2, biological replication 1 |
| GSM7865206 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 2, biological replication 2 |
| GSM7865207 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 2, biological replication 3 |
| GSM7865208 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 2, biological replication 4 |
| GSM7865209 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 2, biological replication 5 |
| GSM7865210 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 3, biological replication 1 |
| GSM7865211 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 3, biological replication 2 |
| GSM7865212 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 3, biological replication 3 |
| GSM7865213 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 3, biological replication 4 |
| GSM7865214 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 3, biological replication 5 |
| GSM7865215 |
NAFLD patient, NAFLD activity score 5-6, fibrosis stage 3, biological replication 6 |
| GSM7865216 |
NAFLD patient, NAFLD activity score 4-7, fibrosis stage 4, biological replication 1 |
| GSM7865217 |
NAFLD patient, NAFLD activity score 4-7, fibrosis stage 4, biological replication 2 |
| GSM7865218 |
NAFLD patient, NAFLD activity score 4-7, fibrosis stage 4, biological replication 3 |
| GSM7865219 |
NAFLD patient, NAFLD activity score 4-7, fibrosis stage 4, biological replication 4 |
| GSM7865220 |
NAFLD patient, NAFLD activity score 4-7, fibrosis stage 4, biological replication 5 |
| GSM7865221 |
NAFLD patient, NAFLD activity score 4-7, fibrosis stage 4, biological replication 6 |
| GSM8191460 |
HFD fed mice without STZ treatment, 32w, batch 9, biological replication 1 |
| GSM8191461 |
HFD fed mice without STZ treatment, 32w, batch 9, biological replication 2 |
| GSM8191462 |
HFD fed mice without STZ treatment, 32w, batch 9, biological replication 3 |
| GSM8191463 |
Control SCD fed mice without STZ treatment, 32w, batch 9, biological replication 1 |
| GSM8191464 |
Control SCD fed mice without STZ treatment, 32w, batch 9, biological replication 2 |
| GSM8191465 |
Control SCD fed mice without STZ treatment, 32w, batch 9, biological replication 3 |
| GSM8191466 |
Control SCD fed mice without STZ treatment, 32w, batch 9, biological replication 4 |
| GSM8191467 |
STZ+ SCD mice, 32w, batch 9, biological replication 1 |
| GSM8191468 |
STZ+ SCD mice, 32w, batch 9, biological replication 2 |
| GSM8191469 |
STZ+ SCD mice, 32w, batch 9, biological replication 3 |
|
| This SuperSeries is composed of the following SubSeries: |
| GSE246213 |
A Mouse Model for Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatocellular Carcinoma [ATAC-seq] |
| GSE246221 |
A Mouse Model for Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatocellular Carcinoma [RNA-seq] |
|
| Relations |
| BioProject |
PRJNA1032073 |
|
|
|
|
 |
Less...
More...